Advertisements

Ola commences trial rides in Perth

Ola commences trial rides in Perth.....»»

Category: economySource: sifyFeb 14th, 2018

Ola continues its Australian expansion

Ola continues its Australian expansion.....»»

Category: economySource: sifyApr 12th, 2018

Ola officially commences operations in Sydney

Ola officially commences operations in Sydney.....»»

Category: economySource: sifyMar 12th, 2018

Users complain as Patanjali puts "Kimbho" chat app on trial

Users complain as Patanjali puts "Kimbho" chat app on trial.....»»

Category: infotechSource: sifyAug 16th, 2018

Focus: Japan"s Don Quijote rides high on rule-breaking reputation

Focus: Japan"s Don Quijote rides high on rule-breaking reputation.....»»

Category: global-financeSource: reutersAug 14th, 2018

Bayer shares fall 10 percent after Monsanto"s Roundup cancer trial

Bayer shares fall 10 percent after Monsanto"s Roundup cancer trial.....»»

Category: global-financeSource: reutersAug 13th, 2018

Bayer shares slide after Monsanto"s Roundup cancer trial

Bayer shares slide after Monsanto"s Roundup cancer trial.....»»

Category: global-financeSource: reutersAug 13th, 2018

Monsanto ordered to pay $289 million in world"s first Roundup cancer trial

Monsanto ordered to pay $289 million in world"s first Roundup cancer trial.....»»

Category: global-financeSource: reutersAug 10th, 2018

Eicher"s premium valuation ebbs as Royal Enfield rides downhill - Livemint

Eicher"s premium valuation ebbs as Royal Enfield rides downhill - Livemint.....»»

Category: topSource: googlenewsAug 10th, 2018

Tata"s Sanand plant rides on Tiago, Tigor; looks to ramp up production - Business Standard

Tata"s Sanand plant rides on Tiago, Tigor; looks to ramp up production - Business Standard.....»»

Category: topSource: googlenewsAug 7th, 2018

U.S. argues judge failed to take its arguments into account in AT&T trial

U.S. argues judge failed to take its arguments into account in AT&T trial.....»»

Category: global-financeSource: reutersAug 6th, 2018

Arista to pay $400 million to Cisco to resolve court fight

Arista to pay $400 million to Cisco to resolve court fight.....»»

Category: global-financeSource: reutersAug 6th, 2018

You Could Soon Earn Cashbacks On GST For Payments Made Digitally - NDTV

You Could Soon Earn Cashbacks On GST For Payments Made Digitally - NDTV.....»»

Category: topSource: googlenewsAug 4th, 2018

States to offer GST cashbacks to consumers for cashless payments - Times of India

States to offer GST cashbacks to consumers for cashless payments - Times of India.....»»

Category: topSource: googlenewsAug 4th, 2018

U.S. court allows release of bench transcripts in AT&T merger fight

U.S. court allows release of bench transcripts in AT&T merger fight.....»»

Category: global-financeSource: reutersAug 3rd, 2018

Kering rides out China fears with Gucci growth

Kering rides out China fears with Gucci growth.....»»

Category: global-financeSource: reutersJul 26th, 2018

Takeda Announces Phase 3 Trial of ALUNBRIG® (brigatinib) Met Primary Endpoint Demonstrating Superiority in Progression-Free Survival Versus Crizotinib in Patients with ALK+ Advanced NSCLC Who are ALK Inhibitor Naïve

Takeda Announces Phase 3 Trial of ALUNBRIG® (brigatinib) Met Primary Endpoint Demonstrating Superiority in Progression-Free Survival Versus Crizotinib in Patients with ALK+ Advanced NSCLC Who are ALK Inhibitor Naïve.....»»

Category: press-releasesSource: businesswireindiaJul 25th, 2018

Governmt considers cap on number of shared rides by private cars owners - Economic Times

Governmt considers cap on number of shared rides by private cars owners - Economic Times.....»»

Category: topSource: googlenewsJul 25th, 2018

Uber, Lyft suspend driver who live-streamed rides

Uber, Lyft suspend driver who live-streamed rides.....»»

Category: economySource: sifyJul 23rd, 2018

MARKETS LIVE: No-confidence motion debate gets underway; Nifty tests 11k - Business Standard

MARKETS LIVE: No-confidence motion debate gets underway; Nifty tests 11k - Business Standard.....»»

Category: topSource: googlenewsJul 20th, 2018

Boehringer Ingelheim and Lilly announce Trajenta®’s CARMELINA® cardiovascular outcome trial met its primary endpoint

Boehringer Ingelheim and Lilly announce Trajenta®’s CARMELINA® cardiovascular outcome trial met its primary endpoint.....»»

Category: press-releasesSource: businesswireindiaJul 20th, 2018